Phorum.com.gr

Πολλά χρόνια αργότερα ο δημοσιογράφος Κώστας Βαξεβάνης κατά τη διάρκεια έρευνας που πραγματοποιούσε στα αρχεία της Στάζι αποκαλύπτει πως η φωτογραφία είναι μεν γνήσια αλλά η ιστορία πίσω της κατασκευάστηκε από τη μυστική υπηρεσία της Ανατολικής Γερμανίας, μετά από αίτημα των… Βουλγαρικών μυστικών υπηρεσιών. Οι εικονιζόμενοι Γερμανοί δεν ήταν ναζί αλλά αυτομολησαντες.
Μία τεράστια αποκάλυψη από έναν δημοσιογράφο, ιδεολογικά αντίθετο του Κωνσταντίνου Μητσοτάκη. Μία αποκάλυψη που κυριολεκτικά «καθάρισε» το όνομα «Μητσοτάκης», δηλαδή το όνομα του σημερινού πρωθυπουργού.

georgebi έγραψε: 27 Ιούλ 2021, 13:48 Ντροπη σου Άδωνη....

Σου στέλνω περαστικά και ιατρικές συμβουλές

και αυτό ειναι το ''ευχαριστώ σου''

https://twitter.com/ElpomperoJohnny/sta ... 76353?s=20

The efficacy of a drug being promoted by rightwing figures worldwide for treating Covid-19 is in serious doubt after a major study suggesting the treatment is effective against the virus was withdrawn due to “ethical concerns”.

The preprint study on the efficacy and safety of ivermectin – a drug used against parasites such as worms and headlice – in treating Covid-19, led by Dr Ahmed Elgazzar from Benha University in Egypt, was published on the Research Square website in November.

It claimed to be a randomised control trial, a type of study crucial in medicine because it is considered to provide the most reliable evidence on the effectiveness of interventions due to the minimal risk of confounding factors influencing the results. Elgazzar is listed as chief editor of the Benha Medical Journal, and is an editorial board member.

A pharmacist holds the anti-parasite drug ivermectin for sale to the public in Bolivia
Unreliable data: how doubt snowballed over Covid-19 drug research that swept the world
Read more
The study found that patients with Covid-19 treated in hospital who “received ivermectin early reported substantial recovery” and that there was “a substantial improvement and reduction in mortality rate in ivermectin treated groups” by 90%.

But the drug’s promise as a treatment for the virus is in serious doubt after the Elgazzar study was pulled from the Research Square website on Thursday “due to ethical concerns”. Research Square did not outline what those concerns were.